Skip to main content
Clinical Trials/NL-OMON39104
NL-OMON39104CompletedNot Applicable

Spectral Domain Optical Coherence Tomography for Glaucoma Diagnostics - SDOCT & Glaucoma

Oogziekenhuis Rotterdam0 sites600 target enrollmentStarted: TBDLast updated:
Conditions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Sponsor
Enrollment
600

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Observational

Eligibility Criteria

Ages
18 to 99 (—)

Inclusion Criteria

  • All 3 groups:
  • Age >= 18 years and < 85 years.
  • Informed consent.;Group 1:
  • Normal VF in both eyes.;Group 2:
  • Glaucoma diagnosis.
  • VF defects must be reproducible on at least one occasion.;Group 3:
  • Ocular hypertension. Untreated IOP on Goldmann applanation tonometry is 24-32 mm Hg. The appearance of the ONH is no selection criterion. There are no significant VF defects.

Exclusion Criteria

  • All 3 groups:
  • Ophthalmic:
  • BCVA > 0.3 (LogMAR).
  • Refractive error ouside -10.0 to +5.0 D range.
  • Cataract surgery in previous 12 months.
  • Previous refractive or vitreoretinal surgery.
  • Evidence of diabetic retinopathy, diabetic macular edema, or other vitreo-retinal disease.
  • Previous keratoplastic surgery.
  • Diabetes, leukemia, AIDS, uncontrolled systemic hypertension, multiple sclerosis or life threatening disease.;Group 1:
  • Glaucoma in either eye.
  • IOP >= 22 mm Hg in either eye.
  • Untreated occludable angle with iridolenticular contact or evidence of iridolenticular contact or peripheral anterior synechia.
  • Presence of disc hemorrhage.;Group 2:
  • Secondary glaucomas except pigmentary.
  • Evidence of SAP VF abnormality consistent with other disease. ;Group 3:
  • Evidence of SAP VF abnormality consistent with other disease.

Investigators

Sponsor
Oogziekenhuis Rotterdam

Similar Trials